Remove Containment Remove Doctors Remove Hormones Remove Protein
article thumbnail

The Longevity Breakthrough Your Doctor Won't Tell You About

The Pharma Data

Product Name: The Longevity Breakthrough Your Doctor Won't Tell You About. Click here to get The Longevity Breakthrough Your Doctor Won't Tell You About at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

Doctors 52
article thumbnail

Genentech’s Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Designation in Combination With Tecentriq for PD-L1-High Non-Small Cell Lung Cancer

The Pharma Data

TIGIT and PD-L1 are proteins that play a role in suppression of the immune system. Tiragolumab is a monoclonal antibody designed to bind with TIGIT, a protein receptor on immune cells. Tecentriq is a monoclonal antibody designed to bind with a protein called PD-L1. Dual blockade of the TIGIT and PD-L1 pathways.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Metabolic Stretching

The Pharma Data

And, most importantly, your body doesn’t get enough protein. Protein contains essential amino acids which are vital for supporting your body and muscle growth. This program contains everything you need to stretch your way to being leaner, fitter and stronger thanks to its serious metabolic benefits.

article thumbnail

CAPTIVATE Study Shows an IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Chemotherapy-Free Combination Has Potential to Provide Remission After Fixed-Duration Treatment for Chronic Lymphocytic Leukemia (CLL)

The Pharma Data

The BTK protein sends important signals that tell B cells to mature and produce antibodies. Call your doctor for medical advice about side effects. About VENCLEXTA ® /VENCLYXTO ® (venetoclax) VENCLEXTA ® /VENCLYXTO ® (venetoclax) is a first-in-class medicine that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein.

article thumbnail

IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemia (CLL) Phase 3 GLOW Study

The Pharma Data

The BTK protein sends important signals that tell B cells to mature and produce antibodies. VENCLEXTA ® /VENCLYXTO ® (venetoclax) is a first-in-class medicine that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein. VENCLXEXTA/VENCLYXTO targets the BCL-2 protein and works to help restore the process of apoptosis.

article thumbnail

The Menopause Rescue Protocol

The Pharma Data

Because in just a moment I’m going to reveal the REAL cause of pesky menopause symptoms that most doctors and gynecologists don’t know about…. The secret natural compound that scientists from the University of Alicante in Spain say beats hormone replacement therapy (HRT)…. NOT just low estrogen like most doctors suggest….

article thumbnail

The Flat Belly Transformation

The Pharma Data

Your body’s hormones are destroyed from almost a year of starvation. There are so many people out there telling you to try keto, intermittent fasting, vegan, high-protein, high-fat, low-fat, and so much more. This ebook contains the entire plan in an easy to follow manner! Exactly What To Eat and When. Supplements.